A Case of Reversible Infantile Respiratory Chain Deficiency Presenting With Hypotonia, Hyperammonemia, and Failure to

Jessenia C Guerrero1, Helio Pedro2, Sarah Parisotto2

  • 1Department of Pathology, Immunology and Laboratory Medicine, Rutgers-New Jersey Medical School, Newark, New Jersey.

Insights

Reversible infantile respiratory chain deficiency, a rare mitochondrial disorder, can present with hyperammonemia. This condition, marked by muscle weakness, may resolve spontaneously in infants who survive early life.

Area of Science:

  • Genetics
  • Pediatrics
  • Neurology

Background:

  • Reversible infantile respiratory chain deficiency is a rare mitochondrial disorder.
  • It is characterized by severe hypotonia, muscle weakness, and lactic acidosis in infants.
  • Affected infants may spontaneously recover if they survive the initial months.

Observation:

  • A 4-week-old girl presented with hyperammonemia, hypotonia, and failure to thrive.
  • Genetic evaluation did not identify a distinct syndrome, and her condition worsened.
  • Muscle biopsy revealed severe mitochondrial myopathy with COX-negative fibers and ultrastructural mitochondrial abnormalities.

Findings:

  • Molecular studies identified a homoplasmic mutation (m.14674 T>C) in the MT-TE gene.
  • This mutation is associated with reversible cytochrome c oxidase (COX) deficiency.
  • Hyperammonemia, though unusual, was a presenting symptom.

Implications:

  • Hyperammonemia should be considered in the differential diagnosis of infants with suspected reversible infantile respiratory chain deficiency.
  • This case highlights the importance of comprehensive evaluation, including muscle biopsy and molecular studies, for diagnosing rare mitochondrial disorders.
  • Early identification and understanding of presenting symptoms can guide clinical management and improve outcomes for affected infants.

Related Concept Videos

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
901
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
476
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
811
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
526
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
596